Products

EMARKETER delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
PRO+
New data sets, deeper insights, and flexible data visualizations.
Learn More
Reports
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Forecasts
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Charts
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Briefings
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About EMARKETER

Our goal is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Events
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Podcasts
Tune in to EMARKETER's daily, weekly, and monthly podcasts.
Learn More

We predict CVS’ next big post-pandemic move will be a digital health M&A

The news: CVS Health released its Q1 2022 earnings report.

Here are the key results:

  • Total revenues are up 11.2% year-over-year. It posted $69.1 billion in Q1’21 and $76.8 billion in Q1’22.
  • These results slightly outpaced Wall Street analysts’ expectations of $75.39 billion.
  • CVS reported a $2.3 billion profit in Q1.

What led to this? In short, the pandemic.

  • COVID-19 vaccines and tests drove foot traffic to CVS stores, and the retail giant saw a boost in store sales.

CVS’ ancillary healthcare businesses (Aetna and Caremark) also saw a boost thanks to vaccine and testing efforts.

  • Aetna’s revenues grew 12.8% YoY to $23.1 billion. And it saw a spike in membership, hitting 24.5 million members by the end of Q1’21—up from 23.6 million year-over-year.
  • Caremark’s revenues rose 8.6% YoY to $39.4 billion.

What’s next? CVS could eye a major partnership or M&A deal with a primary care disruptor to maintain growth in its healthcare business (akin to Walgreens’ stake in VillageMD).

  • During its investor day event in December 2021, CVS hinted at potentially exploring partnerships to accelerate its primary care endeavors.

We could see CVS make a deal with a digital mental health startup, considering its mental health services saw massive utilization lately.

  • CVS went from supporting 10,000 virtual mental health visits in 2019 to 10 million in 2021, per CEO Karen Lynch.
  • CVS announced its plans to close around 900 of its retail locations (9% of its US footprint)—another sign that it’s looking to build even stronger inroads in the virtual care space.